CochLear Ltd. Unsponsored ADR (CHEOY)
(Delayed Data from OTC)
$112.05 USD
+0.25 (0.22%)
Updated Jul 24, 2024 03:50 PM ET
2-Buy of 5 2
F Value A Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CHEOY 112.05 +0.25(0.22%)
Will CHEOY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CHEOY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHEOY
What Makes CochLear Ltd. Unsponsored ADR (CHEOY) a New Buy Stock
Are Medical Stocks Lagging Masimo (MASI) This Year?
CHEOY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CHEOY
Genetic Technologies appoints Ziirsen as CFO, Company Secretary